Content Author: Kerri Virani
Current Owner: Health promotion
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy, Journal of the American Medical Association: Alison J. Rodger, MD; Valentina Cambiano, PhD; Tina Bruun, RN; Pietro Vernazza, MD; Simon Collins; Jan van Lunzen, PhD; Giulio Maria Corbelli; Vicente Estrada, MD; Anna Maria Geretti, MD; Apostolos Beloukas, PhD; David Asboe, FRCP; Pompeyo Viciana, MD1; Félix Gutiérrez, MD; Bonaventura Clotet, PhD; Christian Pradier, MD; Jan Gerstoft, MD; Rainer Weber, MD; Katarina Westling, MD; Gilles Wandeler, MD; Jan M. Prins, PhD; Armin Rieger, MD; Marcel Stoeckle, MD; Tim Kümmerle, PhD; Teresa Bini, MD; Adriana Ammassari, MD; Richard Gilson, MD; Ivanka Krznaric, PhD; Matti Ristola, PhD; Robert Zangerle, MD; Pia Handberg, RN; Antonio Antela, PhD; Sris Allan, FRCP; Andrew N. Phillips, PhD; Jens Lundgren, MD, JAMA. 2016;316(2):171-181. doi:10.1001/jama.2016.5148
Viral load, Michael Carter, Greta Hughson, NAM, Aidsmap, March 2014
More confidence on zero risk: still no transmissions seen from people with an undetectable viral load in PARTNER study, Gus Cairns, NAM, Aidsmap, July 2016
Pragmatic Open-Label Randomised Trial of Pre-Exposure Prophylaxis: the PROUD study, PROUD, MRC Clinical Trials Unit & Public Health England, February 2015
PROUD study interim analysis finds pre-exposure prophylaxis (PrEP) is highly protective against HIV for gay men and other men who have sex with men in the UK, PROUD, MRC Clinical Trials Unit & Public Health England, October 2014
Viral load and transmission - a factsheet for HIV negative people, by Gus Cairns, NAM, Aidsmap, 16/9/15
Viral load and transmission – a factsheet for people with HIV, by Gus Cairns 16/9/15, NAM, Aidsmap
Is there a cure for HIV and AIDS?, Avert, 1/5/15
Early antiretroviral treatment reduces but does not eliminate HIV reservoir, by Liz Highleyman, NAM, Aidsmap, 24/3/15
What are normal ranges for a CD4 count, the CD4% and the CD4:CD8 ratio?, by Simon Collins, iBase, 19/9/14
How HIV destroys the immune cells, by Dan Cossins, The Scientist, 19/12/13
CD4 cell counts, NAM, Aidsmap, February 2012
The basics - CD4 and viral load booklet, NAM, Aidsmap, February 2012
Adherence, by Michael Carter & Greta Hughson, NAM, Aidsmap, 31/3/12
What does taking your HIV treatment involve?, NAM, Aidsmap, March 2014
Aids info - Education materials - Viral rebound
Common side effects - From Side Effects booklet, NAM, Aidsmap, July 2013
Changing treatment due to side effects, by Michael Carter & Greta Hughson, NAM, Aidsmap, 31/3/12
Monitoring the safety and effectiveness of HIV treatment - From Taking Your HIV Treatment booklet, NAM, Aidsmap, March 2014
How long will I live if I stop taking my HIV medication? - Question answered by Angelina Namiba, iBase, 19/1/12
Prognosis, by Michael Carter & Greta Hughson, NAM, Aidsmap, 13/3/12
HIV basics - What is the life expectancy of someone with HIV?, NAM, Aidsmap
Is treatment prevention?, NAM, Aidsmap
No one with an undetectable viral load – gay or heterosexual – transmits HIV in first two years of PARTNER study, NAM, Aidsmap
BHIVA guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015, Writing Group: Duncan Churchill Chair Laura Waters Vice Chair N Ahmed, B Angus, M Boffito, M Bower, D Dunn, S Edwards, C Emerson, S Fidler, †M Fisher, R Horne, S Khoo, C Leen, N Mackie, N Marshall, F Monteiro, M Nelson, C Orkin, A Palfreeman, S Pett, A Phillips, F Post, A Pozniak, I Reeves, C Sabin, R Trevelion, J Walsh, E Wilkins, I Williams, A Winston
START trial finds that early treatment improves outcomes for people with HIV, NAM, Aidsmap, Gus Cairns, 27/5/15
START trial provides definitive evidence of the benefits of early HIV treatment, NAM, Aidsmap, Liz Highleyman; Produced in collaboration with hivandhepatitis.com, 21/7/15
Your treatment. NAM.
HIV Basic Treatment. NAM.
Anti-HIV drugs. NAM.
Progression to AIDS or death. NAM.
People doing well on HIV therapy have a mortality risk identical to that of HIV-negative peers. NAM.
Decrease in AIDS-related illness and deaths. NAM.
Link with reduced infectiousness and good adherence. BHIVA.